Press Releases

05-13 Genmab A/S : Articles of association dated May 12, 2026 – English PU
05-13 Genmab A/S : has published its Articles of Association PU
05-12 Capital Increase in Genmab as a Result of Employee Warrant Exercise GL
05-11 Genmab - Major Shareholder Announcement AQ
05-08 Major Shareholder Announcement GL
05-07 Genmab A/S : Investor Presentation - May 2026 PU
05-07 Genmab A/S : First Quarter 2026 Financial Results Presentation PU
05-07 Genmab A/S : Interim Report for the First Quarter of 2026 PU
05-07 Genmab Announces Financial Results for the First Quarter of 2026 GL
05-07 Genmab Announces Financial Results for the First Quarter of 2026 AQ
04-17 Genmab A/S : has published its Articles of Association PU
04-17 Genmab A/S Share Capital Reduction GL
04-14 Major Shareholder Announcement GL
04-14 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026 GL
04-13 Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer BU
04-13 Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer GL
04-07 Genmab A/S : AGM 2026 Presentation PU
04-01 Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons GL
04-01 Major Shareholder Announcement GL
03-31 Genmab A/S - Major Shareholder Announcement AQ
03-30 Major Shareholder Announcement GL
03-26 Genmab A/S : Voting Results of the Annual General Meeting 2026 PU
03-23 Genmab A/S : Articles of association dated March 19, 2026 – English PU
03-23 Genmab A/S : has published its Articles of Association PU
03-19 Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab GL
No results for this search